PENTAXIM VACCINE
Product details
Registration number: SIN14795P
Classification: Prescription Only
Active ingredients:
- (Prefilled Syringe) Diphtheria toxoid
- (Prefilled Syringe) Filamentous haemagglutinin
- (Prefilled Syringe) Pertussis toxoid
- (Prefilled Syringe) Poliovirus (inactivated) - Type 1 (Mahoney)
- (Prefilled Syringe) Poliovirus (inactivated) - Type 2 (MEF-1)
- (Prefilled Syringe) Poliovirus (inactivated) - Type 3 (Saukett)
- (Prefilled Syringe) Tetanus toxoid
- (Vial) Haemophilus influenzae type b polysaccharide (polyribosylribitol phosphate) conjugated to Tetanus protein
- (Vial) Tetanus protein (PRP-T)
Strength:
- min. 20 IU (30 Lf)/0.5 mL
- 25 μg/0.5 mL
- 25 μg/0.5 mL
- 29 DU/0.5 mL
- 7 DU/0.5 mL
- 26 DU/0.5 mL
- min. 40 IU (10 Lf) /0.5 mL
- 10 μg/0.5 mL
- 18 - 30 μg/0.5 mL
Dosage form: INJECTION, POWDER, FOR SUSPENSION
Route: INTRAMUSCULAR
Registrant: SANOFI-AVENTIS SINGAPORE PTE. LTD.
ATC code: J07CA06
HSA approval date: 5 June 2015
Manufacturer(s):
- Sanofi Winthrop Industrie, MLE
- Sanofi Winthrop Industrie, VDR
Manufacturing country/countries: FRANCE
What are the HSA registration number and classification for PENTAXIM VACCINE?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN14795P
Classification: Prescription Only
What active ingredients and strength are recorded for PENTAXIM VACCINE?
According to the HSA dataset updated 7 August 2026:
Active ingredients:
- (Prefilled Syringe) Diphtheria toxoid
- (Prefilled Syringe) Filamentous haemagglutinin
- (Prefilled Syringe) Pertussis toxoid
- (Prefilled Syringe) Poliovirus (inactivated) - Type 1 (Mahoney)
- (Prefilled Syringe) Poliovirus (inactivated) - Type 2 (MEF-1)
- (Prefilled Syringe) Poliovirus (inactivated) - Type 3 (Saukett)
- (Prefilled Syringe) Tetanus toxoid
- (Vial) Haemophilus influenzae type b polysaccharide (polyribosylribitol phosphate) conjugated to Tetanus protein
- (Vial) Tetanus protein (PRP-T)
Strength:
- min. 20 IU (30 Lf)/0.5 mL
- 25 μg/0.5 mL
- 25 μg/0.5 mL
- 29 DU/0.5 mL
- 7 DU/0.5 mL
- 26 DU/0.5 mL
- min. 40 IU (10 Lf) /0.5 mL
- 10 μg/0.5 mL
- 18 - 30 μg/0.5 mL
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for PENTAXIM VACCINE?
According to the HSA dataset updated 7 August 2026:
Dosage form: INJECTION, POWDER, FOR SUSPENSION
Route: INTRAMUSCULAR
Who is the recorded registrant for PENTAXIM VACCINE?
According to the HSA dataset updated 7 August 2026:
Registrant: SANOFI-AVENTIS SINGAPORE PTE. LTD.
Which manufacturers and countries are listed for PENTAXIM VACCINE?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s):
- Sanofi Winthrop Industrie, MLE
- Sanofi Winthrop Industrie, VDR
Manufacturing country/countries: FRANCE
Where can I look up PENTAXIM VACCINE in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN14795P or the exact product name PENTAXIM VACCINE. The general register link does not preselect this product.
What are the source dates for this PENTAXIM VACCINE record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this PENTAXIM VACCINE record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN14795P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)